Neuren Pharmaceuticals Limited
NURPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3 | $17 | $40 | $37 |
| Short-Term Investments | $219 | $211 | $0 | $0 |
| Receivables | $158 | $14 | $1 | $1 |
| Inventory | $15 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $4 | $2 | $2 |
| Total Curr. Assets | $399 | $247 | $43 | $40 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $10 | $1 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $10 | $1 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $410 | $248 | $43 | $40 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $0 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $37 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $44 | $5 | $1 | $1 |
| Total Curr. Liab. | $46 | $43 | $2 | $1 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $46 | $43 | $2 | $1 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $165 | $173 | $168 | $168 |
| Retained Earnings | $180 | $38 | -$119 | -$119 |
| AOCI | $18 | -$6 | -$7 | -$9 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $364 | $205 | $42 | $39 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $410 | $248 | $43 | $40 |
| Net Debt | -$3 | -$17 | -$40 | -$37 |